Antiviral drugs Market Size, Share, Trends and Forecast (2035)

Antiviral drugs Market Size, Share, Trends and Forecast (2035)

The Antiviral Drugs Market is estimated to grow at a CAGR of 6.3% during the period 2022–2035, claims Roots Analysis. Over the years, there has been a growing focus on the development of safe and effective novel antiviral drugs therapeutics owing to the rising cases of life-threatening viral diseases

novel antiviral drugs therapeutics

The study features an in-depth analysis, highlighting the capabilities of antiviral drug developers engaged in this domain. Amongst other elements, the report features:

• A detailed assessment of the current market landscape of commercially available antiviral drugs.

• A detailed assessment of the current market landscape of clinical-stage antiviral drugs.

• An analysis of the partnerships that have been inked by stakeholders engaged in this domain, during the period 2019–2022 (till May).

• A detailed analysis of investments that have been made into companies engaged in the antiviral drugs domain, during the period 2019–2022 (till May).

• A qualitative analysis of the five competitive forces under an insightful Porter’s Five Forces framework.

• Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in development of antiviral drugs.

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):

Mechanism of Action

• Fusion Inhibitors

• DNA Polymerases

• Protease Inhibitors

• Reverse Transcriptase Inhibitors

• Other Mechanisms

• Target Indication

• Human Immunodeficiency Virus Infection

• Hepatitis

• Herpes Simplex Virus Infection

• Cytomegalovirus Infection\

• Influenza

• Coronavirus Infection

• Other Target Indications

Type of Drug Target

• Virus Targets

• Host Targets

Type of Therapy

• Monotherapy

• Combination Therapy

Key Geographical Regions

• North America

• Europe

• Asia-Pacific

• Latin America

• MENA

• Rest of the World

Key companies covered in the report

• AbbVie

• AstraZeneca

• Bristol-Myers Squibb

• Genentech

• Gilead Sciences

• GlaxoSmithKline (GSK)

• Johnson & Johnson

• Merck

• Novartis

• Pfizer

• Roche

• ViiV Healthcare

For additional details, please visit https://www.rootsanalysis.com/reports/antiviral-drugs-market.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com